Forty seven, inc. (FTSV)
CashFlow / Quarterly
Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18
Cash flows from operating activities:
Net loss

-26,236

-15,163

-23,206

-23,016

-17,214

-21,659

-16,722

-14,775

Adjustments to reconcile net loss to net cash used in operating activities:
Stock-based compensation

1,524

1,208

1,125

1,104

1,113

1,271

616

431

Depreciation and amortization

137

153

117

116

112

96

97

96

Amortization of right-of-use assets

304

298

264

197

0

0

0

0

Accretion of discounts on marketable securities

70

247

342

388

451

113

96

84

Realized gain on sale of available-for-sale securities

0

2

2

2

0

0

0

0

Change in fair value of contingent repayment obligation

-2,567

25

-6

-6

-331

0

0

0

Changes in operating assets and liabilities:
Prepaid expenses and other current assets

-2,153

-1,278

583

4,443

213

3,025

149

-1,002

Other assets

206

2,065

-1,474

-146

742

-1,481

782

630

Accounts payable

5,478

-5,189

4,528

-808

731

788

-1,568

965

Accrued liabilities

-7,738

7,060

2,315

-1,744

3,660

-208

-39

801

Deferred grant funding

176

-156

-610

1,607

-2,390

-1,431

-200

3,006

Lease related liabilities

-347

-336

-452

-78

-37

-30

-28

-28

Net cash used in operating activities

-22,258

-13,186

-15,366

-27,303

-15,099

-22,831

-18,871

-9,216

Cash flows from investing activities:
Purchases of available-for-sale securities

0

97,221

35,173

33,646

3,956

121,703

1,990

14,378

Proceeds from sales of available-for-sale securities

0

0

0

3,996

0

0

0

0

Proceeds from maturities of available-for-sale securities

19,750

43,700

52,444

60,283

6,763

36,113

14,440

20,925

Net cash provided by (used in) investing activities

19,722

-53,779

17,201

30,633

2,510

-85,696

12,450

6,547

Cash flows from financing activities:
Payments of deferred offering costs

-

-

143

0

-

-

1,848

520

Proceeds from issuance of common stock upon ESPP purchase

0

271

0

588

0

0

0

0

Proceeds from issuance of common stock upon exercise of stock options

704

24

613

789

125

11

155

0

Net cash provided by financing activities

184,567

80,899

470

1,377

0

118,839

-1,693

-520

Net increase (decrease) in cash and cash equivalents

182,031

13,934

2,305

4,707

-12,589

10,312

-8,114

-3,189

Noncash investing and financing activities:
Deferred offering costs included in accounts payable and accrued liabilities

-

-326

326

0

-

-1,573

884

813